|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01429909 |
|
Date of registration:
|
07/07/2011 |
|
Primary sponsor: |
|
|
Public title:
|
Optimization of fMRI for the Study of Basal Ganglia Activation in Parkinson's Disease
|
|
Scientific title:
|
Optimization of fMRI for the Study of Basal Ganglia Activation in Parkinson's Disease: T2* Measurement in the Cortex and the Basal Ganglia |
|
Date of first enrolment:
|
February 2011 |
|
Target sample size:
|
80 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT01429909 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
|
|
|
Countries of recruitment
|
|
France
| | | | | | | |
|
Contacts
|
|
Name:
|
Patrick LACARIN |
|
Address:
|
|
|
Telephone:
|
04 73 75 11 95 |
|
Email:
|
placarin@chu-clermontferrand.fr |
|
Affiliation:
|
|
|
|
Name:
|
Patrick LACARIN |
|
Address:
|
|
|
Telephone:
|
04 73 75 11 95 |
|
Email:
|
placarin@chu-clermontferrand.fr |
|
Affiliation:
|
|
|
|
Name:
|
Miguel ULLA |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University Hospital, Clermont-Ferrand |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- For patients :
- Patients with idiopathic Parkinson's disease according to UKPDSBB criterias
- Men or women aged between 40 to 80 years
- not treated with deep brain stimulation
For healthy subjects
- Men or women aged between 40 to 80 years
Exclusion Criteria:
For patients
- Dementia (MMS<24)
- Contraindication to MRI.
- Under guardianship
- In excluding period for another study
For healthy subjects
- Antecedent of neurodegenerative diseases or psychiatric diseases
- Contraindication to MRI
- Under guardianship
- In excluding period for another study
Age minimum:
40 Years
Age maximum:
80 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Parkinson's Disease
|
|
Intervention(s)
|
|
Device: MAGNETOM Avanto (MRI device)
|
|
Primary Outcome(s)
|
|
The quantitative measurement of T2* in the cortex and basal ganglia using MRI, made à J0.
[Time Frame: at day 1]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|